Risk Factors Update Summary
- Addition of "reimbursement" to risks related to government and third-party payors could impact revenue.
- Centralized manufacturing operations pose a risk; any disruption could increase expenses and decrease revenue.
- Introduction of new products by competitors, like Medtronic's Penditure device, may lead to price reductions.
- Failure to manage growth periods could negatively impact market and clinical development and training.
- Cybersecurity risks highlighted, unauthorized access attempts and remote work vulnerabilities may impact operations.
- Failure to protect information technology systems could lead to operational disruptions and increased costs.
- Changes in FDA requirements could impact product manufacturing and cause delays in shipment.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1323885&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.